Cargando…

The effect of neuromuscular electrical stimulation on serum glucose levels in children and adolescents with type-1 diabetes mellitus: a single group clinical trial

BACKGROUND: This study aimed to evaluate the effect of Neuromuscular Electrical Stimulation (NMES) on serum glucose level in children and adolescents with type-1 diabetes. METHODS: This before-after, single-group, clinical trial was conducted on 29 patients with type-1 diabetes mellitus with the age...

Descripción completa

Detalles Bibliográficos
Autores principales: Fallah, Fatemeh, Alijanpour, Morteza, Khafri, Soraya, Pournasrollah, Mohammad, Talebi, Ghadam Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552160/
https://www.ncbi.nlm.nih.gov/pubmed/36221091
http://dx.doi.org/10.1186/s12902-022-01149-6
_version_ 1784806194814124032
author Fallah, Fatemeh
Alijanpour, Morteza
Khafri, Soraya
Pournasrollah, Mohammad
Talebi, Ghadam Ali
author_facet Fallah, Fatemeh
Alijanpour, Morteza
Khafri, Soraya
Pournasrollah, Mohammad
Talebi, Ghadam Ali
author_sort Fallah, Fatemeh
collection PubMed
description BACKGROUND: This study aimed to evaluate the effect of Neuromuscular Electrical Stimulation (NMES) on serum glucose level in children and adolescents with type-1 diabetes. METHODS: This before-after, single-group, clinical trial was conducted on 29 patients with type-1 diabetes mellitus with the age range of 7–18 years. The patients underwent NMES in two 20-minute phases on the quadriceps and hamstrings muscles, three sessions per week for a period of 8 weeks. Fasting Blood Sugar (FBS), measured in two ways, by glucometer and laboratory testing, was considered as the primary outcome and the glycated hemoglobin (HbA1c) and the total daily dose (TDD) of insulin were measured as the secondary outcomes. The laboratory FBS and HbA1c were measured 1 day before the intervention (as a baseline value) and then 2 and 6 weeks after the last session of intervention. FBS by glucometer and total daily dose of insulin were recorded daily from 2 weeks before the intervention to the last day of the intervention and consequently, the weekly average of these variables was calculated and used for statistical analysis. RESULTS: The serum level of FBS (measured by glucometer) and the total daily dose of insulin reduced significantly 2 weeks after beginning of intervention. The laboratory serum level of FBS decreased significantly in the second week after the end of intervention compared to the baseline values. Although the HbA1c level decreased at follow-up period (2 and 6 weeks after the intervention), it was not significant. CONCLUSION: It seems that 8 weeks of NMES has beneficial effects on the reduction of FBS and TDD of insulin therefore, it could be suggested as the contributory treatment in management of children and adolescents with type-1 diabetes. TRIAL REGISTRATION: The study was registered at https://fa.irct.ir/user/trial/51739/view (IRCT20100523003998N1) in date of 25/10/2020.
format Online
Article
Text
id pubmed-9552160
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-95521602022-10-11 The effect of neuromuscular electrical stimulation on serum glucose levels in children and adolescents with type-1 diabetes mellitus: a single group clinical trial Fallah, Fatemeh Alijanpour, Morteza Khafri, Soraya Pournasrollah, Mohammad Talebi, Ghadam Ali BMC Endocr Disord Research BACKGROUND: This study aimed to evaluate the effect of Neuromuscular Electrical Stimulation (NMES) on serum glucose level in children and adolescents with type-1 diabetes. METHODS: This before-after, single-group, clinical trial was conducted on 29 patients with type-1 diabetes mellitus with the age range of 7–18 years. The patients underwent NMES in two 20-minute phases on the quadriceps and hamstrings muscles, three sessions per week for a period of 8 weeks. Fasting Blood Sugar (FBS), measured in two ways, by glucometer and laboratory testing, was considered as the primary outcome and the glycated hemoglobin (HbA1c) and the total daily dose (TDD) of insulin were measured as the secondary outcomes. The laboratory FBS and HbA1c were measured 1 day before the intervention (as a baseline value) and then 2 and 6 weeks after the last session of intervention. FBS by glucometer and total daily dose of insulin were recorded daily from 2 weeks before the intervention to the last day of the intervention and consequently, the weekly average of these variables was calculated and used for statistical analysis. RESULTS: The serum level of FBS (measured by glucometer) and the total daily dose of insulin reduced significantly 2 weeks after beginning of intervention. The laboratory serum level of FBS decreased significantly in the second week after the end of intervention compared to the baseline values. Although the HbA1c level decreased at follow-up period (2 and 6 weeks after the intervention), it was not significant. CONCLUSION: It seems that 8 weeks of NMES has beneficial effects on the reduction of FBS and TDD of insulin therefore, it could be suggested as the contributory treatment in management of children and adolescents with type-1 diabetes. TRIAL REGISTRATION: The study was registered at https://fa.irct.ir/user/trial/51739/view (IRCT20100523003998N1) in date of 25/10/2020. BioMed Central 2022-10-11 /pmc/articles/PMC9552160/ /pubmed/36221091 http://dx.doi.org/10.1186/s12902-022-01149-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Fallah, Fatemeh
Alijanpour, Morteza
Khafri, Soraya
Pournasrollah, Mohammad
Talebi, Ghadam Ali
The effect of neuromuscular electrical stimulation on serum glucose levels in children and adolescents with type-1 diabetes mellitus: a single group clinical trial
title The effect of neuromuscular electrical stimulation on serum glucose levels in children and adolescents with type-1 diabetes mellitus: a single group clinical trial
title_full The effect of neuromuscular electrical stimulation on serum glucose levels in children and adolescents with type-1 diabetes mellitus: a single group clinical trial
title_fullStr The effect of neuromuscular electrical stimulation on serum glucose levels in children and adolescents with type-1 diabetes mellitus: a single group clinical trial
title_full_unstemmed The effect of neuromuscular electrical stimulation on serum glucose levels in children and adolescents with type-1 diabetes mellitus: a single group clinical trial
title_short The effect of neuromuscular electrical stimulation on serum glucose levels in children and adolescents with type-1 diabetes mellitus: a single group clinical trial
title_sort effect of neuromuscular electrical stimulation on serum glucose levels in children and adolescents with type-1 diabetes mellitus: a single group clinical trial
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552160/
https://www.ncbi.nlm.nih.gov/pubmed/36221091
http://dx.doi.org/10.1186/s12902-022-01149-6
work_keys_str_mv AT fallahfatemeh theeffectofneuromuscularelectricalstimulationonserumglucoselevelsinchildrenandadolescentswithtype1diabetesmellitusasinglegroupclinicaltrial
AT alijanpourmorteza theeffectofneuromuscularelectricalstimulationonserumglucoselevelsinchildrenandadolescentswithtype1diabetesmellitusasinglegroupclinicaltrial
AT khafrisoraya theeffectofneuromuscularelectricalstimulationonserumglucoselevelsinchildrenandadolescentswithtype1diabetesmellitusasinglegroupclinicaltrial
AT pournasrollahmohammad theeffectofneuromuscularelectricalstimulationonserumglucoselevelsinchildrenandadolescentswithtype1diabetesmellitusasinglegroupclinicaltrial
AT talebighadamali theeffectofneuromuscularelectricalstimulationonserumglucoselevelsinchildrenandadolescentswithtype1diabetesmellitusasinglegroupclinicaltrial
AT fallahfatemeh effectofneuromuscularelectricalstimulationonserumglucoselevelsinchildrenandadolescentswithtype1diabetesmellitusasinglegroupclinicaltrial
AT alijanpourmorteza effectofneuromuscularelectricalstimulationonserumglucoselevelsinchildrenandadolescentswithtype1diabetesmellitusasinglegroupclinicaltrial
AT khafrisoraya effectofneuromuscularelectricalstimulationonserumglucoselevelsinchildrenandadolescentswithtype1diabetesmellitusasinglegroupclinicaltrial
AT pournasrollahmohammad effectofneuromuscularelectricalstimulationonserumglucoselevelsinchildrenandadolescentswithtype1diabetesmellitusasinglegroupclinicaltrial
AT talebighadamali effectofneuromuscularelectricalstimulationonserumglucoselevelsinchildrenandadolescentswithtype1diabetesmellitusasinglegroupclinicaltrial